| Date Filed | Type | Description |
| 03/14/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 87,719 restricted stock units
@ $0 |
|
| 03/07/2023 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 45,289 restricted stock units
@ $0
Granted 229,358 restricted stock units
@ $0
Granted 458,716 options to buy
@ $0 |
|
| 03/15/2022 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 87,719 restricted stock units
@ $0 |
|
| 03/03/2022 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 36,197 restricted stock units
@ $0
Granted 181,159 restricted stock units
@ $0
Granted 362,318 options to buy
@ $0 |
|
| 11/09/2021 |
4
| Konidaris Tasos (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Disposed/sold 50,000 options to buy
@ $4.12, valued at
$206k
Disposed/sold 50,000 options to buy
@ $3.35, valued at
$167.5k
Disposed/sold 100,000 options to buy
@ $2.29, valued at
$229k
Disposed/sold 102,040 options to buy
@ $4.44, valued at
$453.1k
Disposed/sold 116,370 options to buy
@ $3.58, valued at
$416.6k
|
|
| 05/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/15/2021 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Exercised 87,719 restricted stock units
@ $0 |
|
| 03/03/2021 |
4
| Konidaris Tasos (Executive Vice President & CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 144,788 restricted stock units
@ $0
Granted 289,576 options to buy
@ $0 |
|
| 05/14/2020 |
4
| Konidaris Tasos (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 102,040 options to buy
@ $4.44, valued at
$453.1k
|
|
| 03/16/2020 |
4
| Konidaris Tasos (SVP and CFO) has filed a Form 4 on Amneal Pharmaceuticals, Inc.|
Txns:
| Granted 350,877 restricted stock units
@ $0
Granted 701,754 options to buy
@ $0 |
|
| 03/16/2020 |
3
| Konidaris Tasos (SVP and CFO) has filed a Form 3 on Amneal Pharmaceuticals, Inc. |
| 05/16/2019 |
4
| Konidaris Tasos (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 100,000 options to buy
@ $2.29, valued at
$229k
|
|
| 07/30/2018 |
4
| Konidaris Tasos (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.35, valued at
$167.5k
|
|
| 06/30/2017 |
4
| Konidaris Tasos (Director) has filed a Form 4 on Kadmon Holdings, Inc.|
Txns:
| Granted 50,000 options to buy
@ $4.12, valued at
$206k
|
|
| 02/17/2017 |
3
| Konidaris Tasos (Director) has filed a Form 3 on Kadmon Holdings, Inc. |
| 05/31/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/07/2013 |
4
| Konidaris Tasos (Director) has filed a Form 4 on DELCATH SYSTEMS, INC.|
Txns:
| Granted 33,000 shares
@ $0 |
|
| 07/09/2012 |
4
| Konidaris Tasos (Director) has filed a Form 4 on DELCATH SYSTEMS INC|
Txns:
| Granted 54,586 options to buy
@ $2, valued at
$109.2k
|
|
| 07/09/2012 |
3
| Konidaris Tasos (Director) has filed a Form 3 on DELCATH SYSTEMS INC |
| 03/18/2011 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Granted 18 shares
@ $77.57, valued at
$1.4k
Paid exercise price by delivering 7 shares
@ $80.45, valued at
$563.2 |
|
| 03/08/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/15/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/17/2010 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Granted 20 shares
@ $68.655, valued at
$1.4k
|
|
| 06/18/2010 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Granted 19 shares
@ $73.195, valued at
$1.4k
|
|
| 03/22/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2010 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Paid exercise price by delivering 297 shares
@ $69.96, valued at
$20.8k
|
|
| 03/03/2010 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Granted 3,867 shares
@ $0 |
|
| 02/24/2010 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW|
Txns:
| Paid exercise price by delivering 469 shares
@ $71.23, valued at
$33.4k
Paid exercise price by delivering 564 shares
@ $70.62, valued at
$39.8k
|
|
| 02/16/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/25/2009 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW |
| 02/23/2009 |
4
| Konidaris Tasos (SVP, CFO) has filed a Form 4 on DUN & BRADSTREET CORP/NW |